Indivior’s top shareholder — one of the largest institutional investors in the City — is unlikely oppose its plans to move to the United States. Indivior, a company that specializes
Healthcare11- Page
168Articles
The largest British pharmaceutical group has acquired a Canadian firm that is developing the next generation of cancer treatments. This is its second acquisition this week, aimed at boosting its
Pfizer is selling a stake of its former joint venture in consumer healthcare, Haleon. The sale will be worth approximately £2.3 billion. The American drug company intends to reduce its
The largest pharmaceutical company in Britain has signed a deal to buy a French company that specializes in rare diseases for more than $1 billion. This is part of its
Halma has acquired a company which makes devices for early detection and prevention cervical cancer. The FTSE 100 manufacturer of health and safety products has reached an agreement for Rovers
According to data from the European Health Agency, more than one billion dollars of Pfizer Covid-19 antiviral medications procured by Pfizer in Europe were wasted because strict controls on who
The demand for private medical insurance has soared. Unprecedented waiting lists in the UK NHS, and a crisis within primary care in the country have pushed it to its highest
The landscape of vaccine technology is witnessing a revolutionary change with the introduction of TNX-1800, a next-generation COVID-19 vaccine developed by Tonix Pharmaceuticals. Led by CEO Dr. Seth Lederman, the
